• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性心律失常综合征不完全外显和表现度可变的决定因素。

Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes.

机构信息

Mayo Graduate and Medical Schools, Mayo Clinic, Rochester, MN, USA.

出版信息

Transl Res. 2013 Jan;161(1):1-14. doi: 10.1016/j.trsl.2012.08.005. Epub 2012 Sep 17.

DOI:10.1016/j.trsl.2012.08.005
PMID:22995932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3624763/
Abstract

Mutations in genes encoding ion channel pore-forming α-subunits and accessory β-subunits as well as intracellular calcium-handling proteins that collectively maintain the electromechanical function of the human heart serve as the underlying pathogenic substrate for a spectrum of sudden cardiac death (SCD)-predisposing heritable cardiac arrhythmia syndromes, including long QT syndrome (LQTS), short QT syndrome (SQTS), Brugada syndrome (BrS), and catecholaminergic polymorphic ventricular tachycardia (CPVT). Similar to many Mendelian disorders, the cardiac "channelopathies" exhibit incomplete penetrance, variable expressivity, and phenotypic overlap, whereby genotype-positive individuals within the same genetic lineage assume vastly different clinical courses as objectively assessed by phenotypic features such electrocardiographic abnormalities and number/type of cardiac events. In this Review, we summarize the current understanding of the global architecture of complex electrocardiographic traits such as the QT interval, focusing on the role of common genetic variants in the modulation of ECG parameters in health and the environmental and genetic determinants of incomplete penetrance and variable expressivity in the heritable cardiac arrhythmia syndromes most likely to be encountered in clinical practice.

摘要

编码离子通道孔形成α亚基和辅助β亚基以及细胞内钙处理蛋白的基因突变,共同维持着人类心脏的机电功能,这些突变是一系列易导致心源性猝死(SCD)的遗传性心律失常综合征的潜在致病基础,包括长 QT 综合征(LQTS)、短 QT 综合征(SQTS)、Brugada 综合征(BrS)和儿茶酚胺能多形性室性心动过速(CPVT)。与许多孟德尔疾病一样,心脏“通道病”表现出不完全外显率、可变表达性和表型重叠,即在同一遗传谱系中基因型阳性的个体,根据心电图异常和心脏事件的数量/类型等表型特征进行客观评估,其临床表现差异很大。在这篇综述中,我们总结了目前对复杂心电图特征(如 QT 间期)的全球结构的理解,重点介绍了常见遗传变异在调节心电图参数方面的作用,以及在遗传性心律失常综合征中不完全外显率和可变表达性的环境和遗传决定因素,这些综合征在临床实践中最有可能遇到。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781f/3624763/71fc71d3ce10/nihms412728f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781f/3624763/0996563b9f03/nihms412728f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781f/3624763/d02b757359cb/nihms412728f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781f/3624763/b9c7004e7797/nihms412728f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781f/3624763/bf71cc4f4650/nihms412728f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781f/3624763/179ee2359d52/nihms412728f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781f/3624763/71fc71d3ce10/nihms412728f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781f/3624763/0996563b9f03/nihms412728f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781f/3624763/d02b757359cb/nihms412728f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781f/3624763/b9c7004e7797/nihms412728f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781f/3624763/bf71cc4f4650/nihms412728f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781f/3624763/179ee2359d52/nihms412728f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/781f/3624763/71fc71d3ce10/nihms412728f6.jpg

相似文献

1
Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes.遗传性心律失常综合征不完全外显和表现度可变的决定因素。
Transl Res. 2013 Jan;161(1):1-14. doi: 10.1016/j.trsl.2012.08.005. Epub 2012 Sep 17.
2
Role of pharmacotherapy in cardiac ion channelopathies.心脏离子通道病的药物治疗作用。
Pharmacol Ther. 2015 Nov;155:132-42. doi: 10.1016/j.pharmthera.2015.09.002. Epub 2015 Sep 12.
3
Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.遗传性通道病的机制和临床处理:长 QT 综合征、Brugada 综合征、儿茶酚胺多形性室性心动过速和短 QT 综合征。
Heart Rhythm. 2009 Aug;6(8 Suppl):S51-5. doi: 10.1016/j.hrthm.2009.02.009. Epub 2009 Feb 12.
4
Role of pharmacotherapy in cardiac ion channelopathies.药物治疗在心脏离子通道病中的作用。
Curr Vasc Pharmacol. 2009 Jul;7(3):358-66. doi: 10.2174/157016109788340794.
5
Arrhythmogenic hereditary syndromes: Brugada Syndrome, long QT syndrome, short QT syndrome and CPVT.致心律失常性遗传性综合征:布加综合征、长QT综合征、短QT综合征和儿茶酚胺敏感性多形性室性心动过速。
Minerva Cardioangiol. 2010 Dec;58(6):623-36.
6
Channelopathies, genetic testing and risk stratification.离子通道病、基因检测与风险分层
Int J Cardiol. 2017 Jun 15;237:53-55. doi: 10.1016/j.ijcard.2017.03.063. Epub 2017 Mar 18.
7
Primary Electrical Heart Disease-Principles of Pathophysiology and Genetics.原发性心电疾病——病理生理学和遗传学原理。
Int J Mol Sci. 2024 Feb 2;25(3):1826. doi: 10.3390/ijms25031826.
8
Human Genetics of Cardiac Arrhythmias.心律失常的人类遗传学。
Adv Exp Med Biol. 2024;1441:1033-1055. doi: 10.1007/978-3-031-44087-8_66.
9
Cardiac channelopathies: genetic and molecular mechanisms.心脏通道病:遗传和分子机制。
Gene. 2013 Mar 15;517(1):1-11. doi: 10.1016/j.gene.2012.12.061. Epub 2012 Dec 22.
10
Sudden cardiac death in Long QT syndrome (LQTS), Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia (CPVT).长 QT 综合征(LQTS)、Brugada 综合征和儿茶酚胺多形性室性心动过速(CPVT)中的心源性猝死。
Prog Cardiovasc Dis. 2019 May-Jun;62(3):227-234. doi: 10.1016/j.pcad.2019.05.006. Epub 2019 May 9.

引用本文的文献

1
A New High Penetrant Intronic Pathogenic Variant Related to Long QT Syndrome Type 2.一种与2型长QT综合征相关的新型高穿透性内含子致病变异体。
J Clin Med. 2025 Jul 1;14(13):4646. doi: 10.3390/jcm14134646.
2
A Novel Bradycardia-Associated Variant in as a Candidate Modifier in Type 3 Long QT Syndrome: Case Report and Deep In Silico Analysis.一种新型的与心动过缓相关的变异体作为3型长QT综合征的候选修饰因子:病例报告及深度计算机模拟分析
Biomedicines. 2025 Apr 21;13(4):1008. doi: 10.3390/biomedicines13041008.
3
Taking the pulse: Preimplantation genetic testing for inherited cardiac conditions.

本文引用的文献

1
Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.家族性儿茶酚胺多形性室性心动过速的评估:心脏兰尼碱受体突变携带者亲属中的疾病外显率和表现。
Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):748-56. doi: 10.1161/CIRCEP.112.970517. Epub 2012 Jul 10.
2
Inherited calcium channelopathies in the pathophysiology of arrhythmias.遗传性钙通道病在心律失常的病理生理学中的作用。
Nat Rev Cardiol. 2012 Oct;9(10):561-75. doi: 10.1038/nrcardio.2012.93. Epub 2012 Jun 26.
3
Clinical and genetic determinants of torsade de pointes risk.
把脉:遗传性心脏病的植入前基因检测
Genet Med Open. 2023 Jul 20;1(1):100827. doi: 10.1016/j.gimo.2023.100827. eCollection 2023.
4
Comparative transcriptomic analysis uncovers molecular heterogeneity in hepatobiliary cancers.比较转录组分析揭示了肝胆癌中的分子异质性。
Transl Oncol. 2025 Jan;51:102192. doi: 10.1016/j.tranon.2024.102192. Epub 2024 Nov 14.
5
Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions.用于心律失常建模的人诱导多能干细胞衍生心肌细胞(iPSC-CMs):优势、挑战及潜在解决方案
Front Physiol. 2024 Sep 12;15:1475152. doi: 10.3389/fphys.2024.1475152. eCollection 2024.
6
From genes to clinical management: A comprehensive review of long QT syndrome pathogenesis and treatment.从基因到临床管理:长QT综合征发病机制与治疗的全面综述
Heart Rhythm O2. 2024 Jul 15;5(8):573-586. doi: 10.1016/j.hroo.2024.07.006. eCollection 2024 Aug.
7
Development and characterization of the mode-of-action of inhibitory and agonist peptides targeting the voltage-gated sodium channel SCN1B beta-subunit.靶向电压门控钠离子通道 SCN1Bβ亚基的抑制性和激动性肽的作用模式的开发和表征。
J Mol Cell Cardiol. 2024 Sep;194:32-45. doi: 10.1016/j.yjmcc.2024.06.008. Epub 2024 Jun 26.
8
Recent Advances in Inherited Cardiac Arrhythmias and Their Genetic Testing.遗传性心律失常及其基因检测的最新进展
Cureus. 2023 Oct 25;15(10):e47653. doi: 10.7759/cureus.47653. eCollection 2023 Oct.
9
Noncoding RNAs and Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Cardiac Arrhythmic Brugada Syndrome.非编码 RNA 与人类诱导多能干细胞衍生的心肌细胞在心律失常性 Brugada 综合征中的作用。
Cells. 2023 Oct 3;12(19):2398. doi: 10.3390/cells12192398.
10
Peripheral temperature dysregulation associated with functionally altered Na1.8 channels.与功能改变的Na1.8通道相关的外周温度调节异常。
Pflugers Arch. 2023 Nov;475(11):1343-1355. doi: 10.1007/s00424-023-02856-2. Epub 2023 Sep 11.
尖端扭转型室性心动过速风险的临床和遗传决定因素。
Circulation. 2012 Apr 3;125(13):1684-94. doi: 10.1161/CIRCULATIONAHA.111.080887.
4
High prevalence of genetic variants previously associated with LQT syndrome in new exome data.新外显子组数据中先前与 LQT 综合征相关的遗传变异的高发生率。
Eur J Hum Genet. 2012 Aug;20(8):905-8. doi: 10.1038/ejhg.2012.23. Epub 2012 Feb 29.
5
Genetic variants in SCN5A promoter are associated with arrhythmia phenotype severity in patients with heterozygous loss-of-function mutation.SCN5A 启动子中的遗传变异与杂合性失活突变患者的心律失常表型严重程度相关。
Heart Rhythm. 2012 Jul;9(7):1090-6. doi: 10.1016/j.hrthm.2012.02.023. Epub 2012 Feb 24.
6
Potassium-channel mutations and cardiac arrhythmias--diagnosis and therapy.钾通道突变与心律失常——诊断与治疗。
Nat Rev Cardiol. 2012 Jan 31;9(6):319-32. doi: 10.1038/nrcardio.2012.3.
7
Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner.KCNQ1 编码的 Kv7.1 钾通道 3' 非翻译区的变异以等位基因特异性方式改变 1 型长 QT 综合征患者的疾病严重程度。
Eur Heart J. 2012 Mar;33(6):714-23. doi: 10.1093/eurheartj/ehr473. Epub 2011 Dec 23.
8
A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes.一项大型候选基因研究确定KCNE1基因D85N多态性可能是药物诱导的尖端扭转型室速的一个调节因素。
Circ Cardiovasc Genet. 2012 Feb 1;5(1):91-9. doi: 10.1161/CIRCGENETICS.111.960930. Epub 2011 Nov 18.
9
A polymorphic miR-155 binding site in AGTR1 is associated with cardiac hypertrophy in Friedreich ataxia.AGTR1 中的一个多态 miR-155 结合位点与弗里德里希共济失调中的心肌肥厚有关。
J Mol Cell Cardiol. 2011 Nov;51(5):848-54. doi: 10.1016/j.yjmcc.2011.07.001. Epub 2011 Jul 12.
10
Genetics of sudden death: focus on inherited channelopathies.遗传性心律失常的遗传学:关注遗传性通道病。
Eur Heart J. 2011 Sep;32(17):2109-18. doi: 10.1093/eurheartj/ehr082. Epub 2011 Apr 9.